A Cancer Doctor Shares Top 5 Breast and GYN Cancer Advances in 2023: #4 Molecular Testing

As we countdown to #2024, let’s look back at some of the top advances in breast and gynecologic cancers in 2023. *This is a list generated by me and is absolutely not all inclusive.

Coming in at #4️⃣: Updates on Molecular Testing. This year:
🧬 We saw an increased focus on genetic testing to see if a person inherited a genetic mutation that increases cancer risk (still not being done as much as it should)
📍Molecular testing of the tumor to guide treatment (ie ESR1 mutation for elacestrant in HR+/HER2- metastatic breast cancer, BRCA/HRD testing for potential use of PARP inhibitors in ovarian cancer, MSI/MMR testing in endometrial cancer and more)
🩸Increasing use of non invasive liquid biopsies to guide treatment (and in future, hopefully screen for recurrence).

Let me know what you think/questions/what else you would add to the list!
#breastcancer #cancersurvivor #ovariancancer #endometrialcancer #cervicalcancer #genetics #genomics